latest newsRead more...
22
Jun 2017GSK wins $235 million from Teva in Coreg patent trial
A US jury has ordered Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than million for infringing a patent covering its blood pressure drug Coreg court documents showed A federal jury in Wilmington Delaware on Tuesday found that Teva willfully infringed the patent in…
22
Jun 2017Seqirus Announces Next Major Advancement in Cell-Based Influenza Vaccine Technology
Seqirus a leading innovator in influenza vaccines and pandemic preparedness today announced the next major advancement in the use of cellbased technology at its stateofthe art manufacturing facility in Holly Springs North Carolina In an industry first Seqirus has successfully produced cellbased influenza vaccine at…
21
Jun 2017Almac Discovery and Debiopharm International SA Announce a Licensing Agreement
Almac Discovery a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer and Debiopharm International SA a Switzerland based specialty pharma company today announced a collaboration to pursue the development of Almac Discoverys Wee kinase inhibitor program Under the terms…
press releasesRead more...
22
Jun 2017Eli Lilly and Company Unveils Expanded Biotechnology Center in San Diego
Eli Lilly and Company announced completion of a million expansion of its Biotechnology Center in San Diego California Lillys new space will help foster and accelerate the discovery of medicines…
22
Jun 2017Protea introduces new molecular imaging technology
Protea Biosciences Group Inc announced its development of new technology that enables the direct molecular imaging of the distribution of metabolites and peptides in human clinical tissue samples The results…
22
Jun 2017Phoenix Based BioNovelus Announces a New Product for the Health Disinfectant Industry
Phoenix June GLOBE NEWSWIRE At the recent ExpoMed Show in Mexico City BioNovelus ONOV Chairman and founder Jean Ekobo was proud to introduce the newest addition to the Companys product…
EventsRead more...
26-28
Jun 20173rd Glycobiology World Congress
Conference Series LLC
Hilton London Docklands Riverside
03-05
Jul 201716th Annual Medicinal & Pharmaceutical Sciences Congress
Conferenceseries Ltd
Kuala Lumpur
TOP ARTICLES
-
1
Nanotechnology-based Inhalation Treatment for Lung Cancer
The lungs are the primary organ of the respiratory system The respiratory system works with the circulatory system to deliver oxygen from the lungs to the cells..
-
2
Improving Biopharma Productivity through Optimal Bioreactor Operation
Generating global revenue of US billion biopharmaceuticals account for one fifth of pharmaceutical market The revenue grows at per cent annually which is doubl..
-
3
Parenteral Preparations
INTRODUCTION Parenteral preparations are defined as solutions suspensionsemulsions for injection or infusion powders for injection or infusion gels for injecti..
-
4
The Impact of Materials Handling on Facility Design and Operation
Materials handling a fundamental decision All too often the design of pharmaceutical OSD production facilities fails to recognise the impact on and the oppo..
-
5
Untapped Opportunities in Southeast Asia
Southeast Asia is a growing pharmaceutical market with an increase in clinical trials in recent years With a population of about million and a total area of m..
-
6
When Orphan Drugs Make All the Difference
Orphan drugs those medications that are typically produced in small quantities for limited patient populations are growing in importance worldwide Once largely ..
Knowledge Bank
-
Interviews
Datwyler Pharma Packaging
Senior Manager Global Scientific Affairs
Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Re..
-
Articles
The European Lead Factory
In drug discovery the search for new chemical equity to be developed into valuable preclinical and clinical candidates is very time and costintensive This is a particular difficulty for academics or small and medium enterprises SMEs who are likely to have limited resources Additionally small companies are often created around a single compound or…
-
Research Insights
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine
Abstract Background Inflammatory breast cancer IBC is a rare aggressive form of breast cancer associated with HER amplification with high risk of metastasis and an estimated median survival of y We performed an openlabel singlearm phase II clinical trial ClinicalTrialsgov NCT to investigate the efficacy and safety of afatinib an irreversible ErbB family inhibitor alone and in combination with vinorelbine…
-
Case Studies
Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study
Abstract Background Slow and cumbersome laboratory diagnostics for Mycobacterium tuberculosis complex MTBC risk delayed treatment and poor patient outcomes Wholegenome sequencing WGS could potentially provide a rapid and comprehensive diagnostic solution In this prospective study we compare realtime WGS with routine MTBC diagnostic workflows Methods We compared…
-
Techno Trends
Evotec and Eternygen to Develop Novel Metabolic Disease Therapy
Evotec and Eternygen announced a drug discovery collaboration to develop novel metabolic disease therapy The two companies will develop novel small molecule inhibitors against an Eternygen target to treat metabolic disease using Evotecs technology platform and broad expertise in drug discovery and preclinical development Eternygen is working on the sodium coupled citrate transporter NaCT a novel target which is a…
-
White Papers
Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper
Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more companies are moving toward ascending regions such as India and China to…
-
Industry Reports
Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review
Sanochemia Pharmazeutika AG Sanochemia is a specialty pharmaceutical company that develops and manufactures of innovative drugs and diagnostics in selected indication areas such as neurodegeneration pain and cancer as well as diagnostic products based on contrast media The companys product portfolio includes radiological products including an array of xray imaging…
Advisory Board
Editorial Section
-
Strategy
Failing Data Integrity Audit is not an Option
The timetomarket of blooming Asian pharmaceutical companies especially from India and China are being slowed by the increasing concerns of global and local regulators over data integrity How can they meet regulators audit expectation on data integrity and provide assurance…
-
Research development
Reviving Pharma R&D Productivity with New Modalities
The pharmaceutical industry is facing a decline in RD productivity However genomics biomarkers and access to human tissue samples are offering a range of well validated but challenging biological targets To seize the opportunity leveraging New Modalities and abolishing silos…
-
Clinical Trails
Patient Recruitment
To address the challenges faced in patient recruitment and retention in clinical trials innovative technologies are being utilised in AsiaPacific as well as other regions to optimise the processes involved From patient matching to improving the consent process technology has…
-
Manufacturing
Added Costs for Added Protections
The Impact of Implementing Safety Features in Pharmaceutical Packaging and Labelling Serialization Unique Device Identification UDI and aggregation catalyse a paradigm shift for the entire industry and are already impacting the pharmaceutical supply chain In…
-
Information Technology
Electronic FDA Submissions
If your time to you is worth savin then you better start swimmin or youll sink like a stone for the times they are a changin Bob Dylan
-
Expert Talk
The Asian Healthcare Market
The Asian market is growing rapidly and along with this expansion comes the issue of drug counterfeiting Bernd offers his insight into the key trends affecting this market and what regulatory authorities are expecting manufacturers…